Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2023-10-25
2024-08-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myosuit in Incomplete Spinal Cord Injury
NCT05605912
Improving Gait Performance in Individuals With Spinal Cord Injuries: an Intervention Using Robotic Exoskeletons
NCT03011099
WIM Exosuit Wearable Soft Robot for Enhancing Walking Activity
NCT07061691
Exoskeleton Training on Balance Control and Turning in Ambulation in Individuals With Incomplete Spinal Cord Injury
NCT06971510
EFFECTS OF ROBOTIC TRAINING ON VASCULAR HEALTH OF INDIVIDUALS WITH SCI
NCT03611803
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: Investigate the effect of a BWS system and soft exosuit on dynamic balance and knee and hip kinematics during gait in people with incomplete spinal cord injury.
Study design: Experimental design.
Study population: Fourteen people with subacute or chronic iSCI (at least 2 weeks after injury) will be included. People with iSCI will be included when having an injury level of C or D on the American Spinal Injury Association Impairment Scale.
Intervention: Participants will visit the Sint Maartenskliniek once and perform overground walking trials in a laboratory setting: regular walking, walking with the ZeroG (BWS system) and walking with the Myosuit (soft exosuit). Each condition consists of 6 walking trials over a distance of 12.5 m.
Main study parameters/endpoints: The main study parameter for dynamic balance during gait will be medio-lateral center of mass excursion. The main study parameter for gait kinematics will be maximum extension of the knee in sagittal plane.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Regular walking
Participants perform 6 overground walking trials (12.5 m) without support system. Participants perform all measurements (regular walking, Myosuit, ZeroG) on one single measurement day.
Myosuit
Participants perform 6 overground walking trials (12.5 m) while wearing the Myosuit. ZeroG and Myosuit intervention will be performed in random order.
ZeroG
Participants perform 6 overground walking trials (12.5 m) while walking in the ZeroG. ZeroG and Myosuit intervention will be performed in random order.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have an injury level of C or D on the American Spinal Injury Association Impairment Scale
* Age ≥ 18 years
* Walking speed between 0.4 and 0.8 m/s (limited community ambulation) (24)
* Must be able to stand up from a chair without deviating to the left or right side for more than 45 degrees during the movement
* Can walk for 10 meter without the assistance of another person but can be assisted by assistive devices such as, crutches, walking sticks or ankle foot orthoses except knee orthoses or walkers
* Reduced knee and/or hip strength (MRC=\<4).
Exclusion Criteria
* Have wounds
* Taller than 195 and smaller than 150 cm
* Body weight of more than 110 kg or less than 45 kg
* Pregnancy
* Flexion contracture in knee or hip in excess of 10 degrees
* Knee varus malposition in excess of 10 degrees or knee valgus malposition in excess of 10 degrees
* Insufficient mastery of the Dutch language
* Psychiatric backgrounds
* Oncological spinal cord injury
* Stoma
* Unsuitable for participation according to the rehabilitation physician or researcher
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sint Maartenskliniek
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Noel Keijsers
Prof N.L.W Keijsers
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bart van den Bemt
Role: PRINCIPAL_INVESTIGATOR
Sint Maartenskliniek
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sint Maartenskliniek
Ubbergen, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.